Financings in Brief: Med-Design Corporation
This article was originally published in The Gray Sheet
Executive SummaryMed-Design Corporation: Files registration statement with the Securities and Exchange Commission for an initial public offering of 1.5 mil. shares of common stock, expected to be sold for between $6.50 and $7 per share. Based in Philadelphia, Med-Design is developing safety devices intended to lower the incidence of accidental needlesticks. The firm's first three products are a safety syringe, a safety phlebotomy set, and a safety catheter. Each product features a retractable needle that is rendered risk-free once therapy is delivered. The 11-employee company anticipates that FDA will determine all three products to be Class II devices and that 510(k)s for all three will be filed by the end of 1995.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.